AIMD
Price
$1.35
Change
+$0.05 (+3.85%)
Updated
Oct 2, 04:57 PM (EDT)
Capitalization
9.82M
Intraday BUY SELL Signals
CRMD
Price
$7.19
Change
-$0.23 (-3.10%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
614.98M
40 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AIMD vs CRMD

AIMD vs CRMD Comparison Chart in %
View a ticker or compare two or three
VS
AIMD vs. CRMD commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIMD is a StrongBuy and CRMD is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
AIMD vs CRMD: Fundamental Ratings
AIMD
CRMD
OUTLOOK RATING
1..100
9210
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
79
Overvalued
PROFIT vs RISK RATING
1..100
10091
SMR RATING
1..100
10019
PRICE GROWTH RATING
1..100
8361
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRMD's Valuation (79) in the Medical Specialties industry is in the same range as AIMD (80) in the null industry. This means that CRMD’s stock grew similarly to AIMD’s over the last 12 months.

CRMD's Profit vs Risk Rating (91) in the Medical Specialties industry is in the same range as AIMD (100) in the null industry. This means that CRMD’s stock grew similarly to AIMD’s over the last 12 months.

CRMD's SMR Rating (19) in the Medical Specialties industry is significantly better than the same rating for AIMD (100) in the null industry. This means that CRMD’s stock grew significantly faster than AIMD’s over the last 12 months.

CRMD's Price Growth Rating (61) in the Medical Specialties industry is in the same range as AIMD (83) in the null industry. This means that CRMD’s stock grew similarly to AIMD’s over the last 12 months.

CRMD's P/E Growth Rating (99) in the Medical Specialties industry is in the same range as AIMD (100) in the null industry. This means that CRMD’s stock grew similarly to AIMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AIMDCRMD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (AIMD: $1.30 vs. CRMD: $7.42)
Brand notoriety: AIMD and CRMD are both not notable
AIMD represents the Electronic Equipment/Instruments, while CRMD is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AIMD: 68% vs. CRMD: 88%
Market capitalization -- AIMD: $9.82M vs. CRMD: $614.98M
AIMD [@Electronic Equipment/Instruments] is valued at $9.82M. CRMD’s [@Biotechnology] market capitalization is $614.98M. The market cap for tickers in the [@Electronic Equipment/Instruments] industry ranges from $12.56K to $120.89B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Electronic Equipment/Instruments] industry is $9.16B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AIMD’s FA Score shows that 0 FA rating(s) are green while CRMD’s FA Score has 1 green FA rating(s).

  • AIMD’s FA Score: 0 green, 5 red.
  • CRMD’s FA Score: 1 green, 4 red.
According to our system of comparison, CRMD is a better buy in the long-term than AIMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AIMD’s TA Score shows that 4 TA indicator(s) are bullish while CRMD’s TA Score has 3 bullish TA indicator(s).

  • AIMD’s TA Score: 4 bullish, 4 bearish.
  • CRMD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AIMD is a better buy in the short-term than CRMD.

Price Growth

AIMD (@Electronic Equipment/Instruments) experienced а -9.72% price change this week, while CRMD (@Biotechnology) price change was -4.50% for the same time period.

The average weekly price growth across all stocks in the @Electronic Equipment/Instruments industry was +1.10%. For the same industry, the average monthly price growth was -1.90%, and the average quarterly price growth was +2.13%.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

CRMD is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Electronic Equipment/Instruments (+1.10% weekly)

This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
AIMD
Daily Signal:
Gain/Loss:
CRMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TDC29.921.08
+3.74%
TERADATA Corp
RBA81.590.20
+0.25%
RB Global
BDL47.23-0.74
-1.54%
Flanigan's Enterprises
SPRC4.55-0.17
-3.60%
SciSparc Ltd.
HKD1.72-0.07
-3.91%
AMTD Digital

AIMD and

Correlation & Price change

A.I.dvisor tells us that AIMD and AGPU have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AIMD and AGPU's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AIMD
1D Price
Change %
AIMD100%
+2.36%
AGPU - AIMD
30%
Poorly correlated
+0.44%
KEYS - AIMD
30%
Poorly correlated
+2.70%
CODX - AIMD
30%
Poorly correlated
+0.93%
MBOT - AIMD
29%
Poorly correlated
N/A
CRMD - AIMD
28%
Poorly correlated
-3.64%
More

CRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRMD has been loosely correlated with IMRX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CRMD jumps, then IMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRMD
1D Price
Change %
CRMD100%
-3.64%
IMRX - CRMD
45%
Loosely correlated
-1.59%
ACRV - CRMD
43%
Loosely correlated
-1.95%
ARTL - CRMD
33%
Poorly correlated
-5.20%
RLYB - CRMD
32%
Poorly correlated
-2.56%
GNLX - CRMD
31%
Poorly correlated
-0.40%
More